Medical News

RSS

Westpak announces formation of cold chain testing division

Westpak Inc., a world class ISO 17025 accredited environmental test laboratory with 2 facilities in California, recently announced the formation of a cold chain testing division dedicated to the testing of packages intended for controlled temperature environments.

13 Aug 2012

Biosense Webster launches new CARTO 3 Multi-Electrode Mapping Version

Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.

13 Aug 2012

Premier healthcare alliance awards new agreements for patient lifts and lateral transfer devices

The Premier healthcare alliance today announced new agreements for patient lifts and lateral transfer devices have been awarded.

13 Aug 2012

Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis

Meritage Pharma, Inc. announced that it has initiated a Phase 2 clinical trial to evaluate oral budesonide suspension (OBS) for the treatment of adolescents and young adults with eosinophilic esophagitis (EoE), an allergic inflammatory condition of the esophagus. EoE is a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation.

13 Aug 2012

Chronic nerve pain: researchers identify which sensory nerve cells are responsible

New research, led by academics at the University of Bristol and published in the journal Pain, has identified the subtypes of sensory nerve cells that are likely to contribute to long-term nerve pain from partial nerve injury. It is hoped this will aid in development of more effective pain killers.

13 Aug 2012

Positive results from Acorda post-marketing commitment study of dalfampridine-ER for MS

Acorda Therapeutics, Inc. today announced top line results from a post-marketing commitment study evaluating a 5mg dose of dalfampridine-ER to improve walking in people with multiple sclerosis. The study failed to confirm efficacy of the 5mg dose.

13 Aug 2012

UTSW reports successful delivery of quintuplets

Three boys and two girls were born Thursday, Aug. 9, to missionaries Carrie and Gavin Jones at UT Southwestern Medical Center, among the first sets of quintuplets delivered nationally so far this year.

13 Aug 2012

NIH awards ADi Phase II SBIR grant to scan Plasmodium falciparum proteome for protective antigens

Antigen Discovery, Inc. today announced that it has received a Phase II Small Business Innovation and Research award from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The three-year award, totaling approximately $ 2.5 million, is a continuation of a Phase I SBIR grant to scan the Plasmodium falciparum proteome for protective antigens.

13 Aug 2012

Orally effective FluCide anti-influenza drug candidate

NanoViricides, Inc. announced today that an anti-influenza drug candidate under its FluCide program is effective when given orally. The Company has received information that a FluCide drug candidate designed for oral administration has shown very strong efficacy in corresponding animal studies.

13 Aug 2012

Roche MagNA Pure 96 System's CE certified IVD version launched

Today, Roche announced the launch of its new CE certified IVD version of the MagNA Pure 96 System for automated sample preparation. By providing a maximum of lot-to-lot consistency and highest quality, the new MagNA Pure 96 System is designed to even better fulfill the needs of diagnostic customers. In 2011, the IVD version of MagNA Pure 96 was already introduced in the US.

From Roche Sequencing and Life Science 13 Aug 2012

Sirona to celebrate 27 and a half year anniversary of CEREC CAD/CAM system

Sirona Dental Systems, the company that pioneered digital dentistry more than 27 years ago and the global number one producer of dental CAD/CAM systems, will celebrate the 27 and a half year anniversary of its industry-changing CEREC CAD/CAM system at the Venetian Resort Hotel Casino August 16-18, 2012.

13 Aug 2012

First Edition: August 13, 2012

Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals - including some nationally recognized ones - will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".

13 Aug 2012

Maternal obesity and neonatal death: an interview with Dr. Jenny Cresswell

It is important to say that levels of maternal obesity in sub-Saharan Africa are low by global standards, but obesity is projected to increase over the next two decades.

13 Aug 2012

Verastem second quarter net loss increases to $6.8 million

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, today reported financial results for the quarter ended June 30, 2012, and also commented on certain corporate accomplishments and plans.

13 Aug 2012

FDA clears Stryker’s Trevo Pro Retriever to treat acute ischemic stroke

Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.

From Stryker 13 Aug 2012

SAIC acquires maxIT Healthcare

Science Applications International Corporation (SAIC) today announced it has completed the acquisition of maxIT Healthcare Holdings, Inc., a leading healthcare IT (Information Technology) consulting firm based in Westfield, Ind.

13 Aug 2012

Researchers uncover how pathological cells activate themselves in chronic lymphocytic leukaemia

Researchers in the group of Prof. Dr. Hassan Jumaa, Centre for Biological Signalling Studies (BIOSS) of the University of Freiburg, Department for Molecular Immunology, have identified a new mechanism that causes immune cells to convert into malignant cancer cells.

13 Aug 2012

Scientists discover new class of polymers that are resistant to bacterial attachment

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures.

13 Aug 2012

Radiation therapy following lumpectomy may benefit older, early-stage breast cancer patients

For the majority of older, early-stage breast cancer patients, radiation therapy following breast conserving surgery may help prevent the need for a later mastectomy, according to research from The University of Texas MD Anderson Cancer Center.

13 Aug 2012

New 3-D view of the body's response to infection

A new 3-D view of the body's response to infection - and the ability to identify proteins involved in the response - could point to novel biomarkers and therapeutic agents for infectious diseases.

13 Aug 2012